Correlation Between Replimune and Unity Biotechnology
Can any of the company-specific risk be diversified away by investing in both Replimune and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Unity Biotechnology, you can compare the effects of market volatilities on Replimune and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Unity Biotechnology.
Diversification Opportunities for Replimune and Unity Biotechnology
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Replimune and Unity is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Replimune i.e., Replimune and Unity Biotechnology go up and down completely randomly.
Pair Corralation between Replimune and Unity Biotechnology
Given the investment horizon of 90 days Replimune Group is expected to generate 1.98 times more return on investment than Unity Biotechnology. However, Replimune is 1.98 times more volatile than Unity Biotechnology. It trades about 0.06 of its potential returns per unit of risk. Unity Biotechnology is currently generating about -0.19 per unit of risk. If you would invest 1,113 in Replimune Group on September 26, 2024 and sell it today you would earn a total of 137.00 from holding Replimune Group or generate 12.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Unity Biotechnology
Performance |
| Timeline |
| Replimune Group |
| Unity Biotechnology |
Replimune and Unity Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Unity Biotechnology
The main advantage of trading using opposite Replimune and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.| Replimune vs. Fate Therapeutics | Replimune vs. Caribou Biosciences | Replimune vs. Karyopharm Therapeutics | Replimune vs. Hookipa Pharma |
| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |